ATP13A1 Peptide
| Code | Size | Price |
|---|
| PSI-46-629P-0.1mg | 0.1mg | £404.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Target Species: Human
Application: Blocking
Storage:
-20°C
Documents
Further Information
Additional Names:
ATP13A, CGI-152, ATP13A, KIAA1825, Probable cation-transporting ATPase 13A1,
Application Note:
ATP13A1 Peptide is used for blocking the activity of ATP13A1 antibody (catalog number 46-629). The ATP13A1 antibody ships at 0.5 mg/mL and the ATP13A1 Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
Buffer:
ATP13A1 peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.
NCBI Gene ID #:
57130
NCBI Official Name:
ATPase type 13A1
NCBI Official Symbol:
ATP13A1
NCBI Organism:
Homo sapiens
Peptide aa Location:
ATP13A1 peptide corresponds to 13 amino acids of ATP13A1.
Physical State:
Lyophilized
Protein Accession #:
NP_065143.2
Protein GI Number:
170016077
Swissprot #:
Q9HD20